Agenus Inc (NASDAQ:AGEN)

3.76
Delayed Data
As of 4:00pm ET
 -0.19 / -4.81%
Today’s Change
3.24
Today|||52-Week Range
6.19
+15.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$576.1M

Company Description

Agenus, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its core technology portfolio consists of Saponin platform and Heat Shock Protein platform. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.

Contact Information

Agenus, Inc.
3 Forbes Road
Lexington Massachusetts 02421-7305
P:(781) 674-4400
Investor Relations:

Employees

Shareholders

Other institutional31.25%
Individual stakeholders21.98%
Mutual fund holders12.77%

Top Executives

Garo H. ArmenChairman & Chief Executive Officer
Christine M. KlaskinPrincipal Accounting Officer & VP-Finance
Karen Higgins ValentineSecretary, Chief Legal & Compliance Officer
James GormanVP-Strategic Planning & Portfolio Management
Michael PlaterHead-Corporate Affairs & Chief of Staff to the CEO